Drawing for EMAVANT

USPTO serial 88057572

EMAVANT

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SWAIN, MICHELE LYNN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMAVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allison Strickland Ricketts

Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for providing, analyzing and generating reports; computer software for data processing; downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceutical and biomedical research, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest; downloadable computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information; downloadable computer software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying dataABANDONED—
035Advertising; business management; business administration; business research and information services; market research and information services; data processing services; business data analysis services in the field of pharmaceuticals and biomedicine; providing statistical, consultancy and reporting services for business purposes using artificial intelligence and machine learning for biomedical research, healthcare institutions and healthcare professionals; business analysis and statistical analysis of healthcare data, biomedical and pharmaceutical research and clinical trial and post-market trial data for business and marketing purposes; systematization and compilation of data in computer databases; business research, market testing and statistical analysis services in the fields of healthcare, biomedicine and pharmaceuticals, and for clinical trials and post-market trials for business and marketing purposes; business advisory services, consultancy and informationABANDONED—
041Education, namely, providing of training in the field of healthcare; providing information in the field of education regarding healthcareABANDONED—
042Scientific and technological services, namely, scientific research and analysis, and diagnostic services for others in the field of pharmaceuticals and biomedicine; scientific research; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; providing on-line non-downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; providing on-line non-downloadable computer software for management of medical practices and research; providing on-line non-downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; providing on-line non-downloadable computer software for accessing, controlling and managing data and information related to healthcare services and patient medical informationABANDONED—
044Providing educational information about healthcare; providing health and medical information; providing internet-based healthcare information; providing information to healthcare professionals regarding patient data; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; medical services; medical services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of a data storage and retrieval systemABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2020NOADDUPLICATE NOA MAILED—
Aug 14, 2020ABN5ABANDONMENT - AFTER PUBLICATION—
Aug 13, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 4, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 4, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 4, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 18, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 22, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2019ALIEASSIGNED TO LIE—
Apr 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2018DOCKASSIGNED TO EXAMINER—
Aug 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance